Trial Profile
Effect of Bevacizumab treatment associated with chemotherapy in patients with non resectable liver metastases from colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jan 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 05 Jan 2018 New trial record